Czech Republic Pharmaceuticals & Healthcare Report Q4 2013: New Research Report Available at Fast Market Research
The Czech healthcare system is facing severe challenges as it struggles to contain budget deficits. At the same time, demand for pharmaceuticals and healthcare is expected to continue its steady growth trajectory, putting pressure on the state and insurers to raise premiums or cut back on services. We believe that pharmaceutical spending will rebound over the short term once funding for the healthcare system is stabilised and the macroeconomic outlook improves in line with the eurozone recovery.
View full press release